Exagen Inc. (XGN) Tops Q2 EPS by 6c

Exagen Inc. (NASDAQ: XGN) reported Q2 EPS of ($0.13), $0.06 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $19.94 million versus the consensus estimate of $17.81 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• St. Kitts and Nevis Integrates Biometric Enrolment With the Passport Process
• Ciena (CIEN) call put ratio 1 call to 1.6 puts into quarter results